Cite
HARVARD Citation
Di Rocco, M. et al. (2022). Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesia. Human molecular genetics. 31 (6), pp. 929-941. [Online].